Nanogen buoyed by EU patent for stroke diagnostic
This article was originally published in Clinica
Executive Summary
Nanogen saw its share price rise over 20% this week after announcing that its SynX Pharma subsidiary had gained a European patent covering a kit and method for diagnosing and distinguishing stroke.